09.14.18
Regulators flag second potential carcinogen in China-made heart drug

The findings have already prompted recalls in more than 50 countries, affecting several Chinese and Indian companies. (iStock) European and North American regulators have said they are examining a second potentially cancer-causing substance in a commonly-used blood pressure drug made by Chinese firm Zhejiang Huahai Pharmaceuticals. Statements from health regulators in the EU, United States